Brain Cancer Global Clinical Trials Review, H1, 2017

GlobalData's clinical trial report, “Brain Cancer Global Clinical Trials Review, H1, 2017" provides an overview of Brain Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Brain Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

– The report provides a snapshot of the global clinical trials landscape

– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

– The Report provides enrollment trends for the past five years

– Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Companies mentioned

F. Hoffmann-La Roche Ltd

Merck & Co Inc

Bristol-Myers Squibb Company

Novartis AG

AstraZeneca Plc

AbbVie Inc

Pfizer Inc

Sanofi

DelMar Pharmaceuticals Inc

Celgene Corp

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Report Guidance 6

GlobalData Clinical Trials Report Coverage 7

Clinical Trials by Region 8

Clinical Trials and Average Enrollment by Country 9

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12

Top Five Countries Contributing to Clinical Trials in Europe 13

Top Countries Contributing to Clinical Trials in North America 14

Top Countries Contributing to Clinical Trials in Middle East and Africa 15

Top Countries Contributing to Clinical Trials in Central and South America 16

Clinical Trials by G7 Countries: Proportion of Brain Cancer to Oncology Clinical Trials 17

Clinical Trials by Phase in G7 Countries 18

Clinical Trials in G7 Countries by Trial Status 19

Clinical Trials by E7 Countries: Proportion of Brain Cancer to Oncology Clinical Trials 21

Clinical Trials by Phase in E7 Countries 22

Clinical Trials in E7 Countries by Trial Status 23

Clinical Trials by Phase 24

In Progress Trials by Phase 25

Clinical Trials by Trial Status 26

Clinical Trials by End Point Status 28

Subjects Recruited Over a Period of Time 29

Clinical Trials by Sponsor Type 30

Prominent Sponsors 31

Top Companies Participating in Brain Cancer Therapeutics Clinical Trials 33

Prominent Drugs 35

Latest Clinical Trials News on Brain Cancer 36

Apr 20, 2017: Medicenna to Present at Bloom Burton & Co. Healthcare Investor Conference 2017 36

Apr 13, 2017: FDA Allows NuvOx Pharma to Run a Phase II Clinical Trial in Brain Cancer 36

Apr 10, 2017: Novogen Update On Phase II Development Plans For GDC-0084 36

Mar 28, 2017: Blaze Bioscience Announces Tumor Paint BLZ-100 Publication in International Journal of Toxicology 37

Clinical Trial Profile Snapshots 38

Appendix 333

Abbreviations 333

Definitions 333

Research Methodology 334

Secondary Research 334

About GlobalData 335

Contact Us 335

Disclaimer 335

Source 336

List of Tables

Brain Cancer Therapeutics, Global, Clinical Trials by Region, 2017* 8

Brain Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9

Brain Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 11

Brain Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 12

Brain Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 13

Brain Cancer Therapeutics Clinical Trials, North America, Top Countries, 2017* 14

Brain Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 15

Brain Cancer Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 16

Proportion of Brain Cancer to Oncology Clinical Trials, G7 Countries (%), 2017* 17

Brain Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 18

Brain Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 19

Proportion of Brain Cancer to Oncology Clinical Trials, E7 Countries (%), 2017* 21

Brain Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 22

Brain Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 23

Brain Cancer Therapeutics, Global, Clinical Trials by Phase, 2017* 24

Brain Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 25

Brain Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2017* 26

Brain Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2017* 28

Brain Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 29

Brain Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 30

Brain Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 31

Brain Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 33

Brain Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 35

List of Figures

Brain Cancer Therapeutics, Global, Clinical Trials by Region (%), 2017* 8

Brain Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9

Brain Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 11

Brain Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 12

Brain Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 13

Brain Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 14

Brain Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2017* 15

Brain Cancer Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2017* 16

Proportion of Brain Cancer to Oncology Clinical Trials, G7 Countries (%), 2017* 17

Brain Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 18

Brain Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 19

Proportion of Brain Cancer to Oncology Clinical Trials, E7 Countries (%), 2017* 21

Brain Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 22

Brain Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 23

Brain Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2017* 24

Brain Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 25

Brain Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2017* 26

Brain Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2017* 28

Brain Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 29

Brain Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 30

Brain Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 31

Brain Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 33

Brain Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 35

GlobalData Methodology 334

    Pricing

Discounts available for multiple purchases.

reportstore@globaldata.com
+44 20 7947 2745

Join our mailing list

Saved reports